Screener
BioCryst Pharmaceuticals BCRX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's common stock shares issued?
- BioCryst Pharmaceuticals (BCRX) reported common stock shares issued of 255.3M in Q2 2026.
- How has BioCryst Pharmaceuticals's common stock shares issued changed year-over-year?
- BioCryst Pharmaceuticals's common stock shares issued increased by 21.6% year-over-year, from 209.9M to 255.3M.
- What is the long-term trend for BioCryst Pharmaceuticals's common stock shares issued?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's common stock shares issued has grown at a 4.3% compound annual growth rate (CAGR), from 187.9M to 213.1M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about BioCryst Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude